We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-13.31%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
–
AUM
$344M
AUM Growth
-$64.7M
Cap. Flow
-$7.41M
Cap. Flow %
-2.16%
Top 10 Hldgs %
23.5%
Holding
482
New
11
Increased
70
Reduced
80
Closed
174

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.42M
2
APTV icon
Aptiv
APTV
+$4.66M
3
LOW icon
Lowe's Companies
LOW
+$3.97M
4
TXN icon
Texas Instruments
TXN
+$3.92M
5
BAH icon
Booz Allen Hamilton
BAH
+$3.71M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$4.62M
2
VLO icon
Valero Energy
VLO
+$4.53M
3
WMT icon
Walmart Inc
WMT
+$4.32M
4
PJAN icon
Innovator US Equity Power Buffer ETF January
PJAN
+$3.75M
5
ISTB icon
iShares Core 1-5 Year USD Bond ETF
ISTB
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 18.8%
2 Healthcare 13%
3 Financials 10.57%
4 Communication Services 8.99%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOXF icon
351
Fox Factory Holding Corp
FOXF
$830M
– –
-19
Closed -$2K
FRPT icon
352
Freshpet
FRPT
$3.07B
– –
-23
Closed -$2K
FSS icon
353
Federal Signal
FSS
$8.08B
– –
-52
Closed -$2K
GD icon
354
General Dynamics
GD
$104B
– –
-18
Closed -$4K
GGG icon
355
Graco
GGG
$13.3B
– –
-28
Closed -$2K
GH icon
356
Guardant Health
GH
$21.4B
– –
-7
Closed –
GLOB icon
357
Globant
GLOB
$1.65B
– –
-9
Closed -$2K
GNRC icon
358
Generac Holdings
GNRC
$12.9B
– –
-8
Closed -$2K
GSBD icon
359
Goldman Sachs BDC
GSBD
$1.01B
– –
-11,780
Closed -$231K
GSK icon
360
GSK
GSK
$103B
$0 οΉ€0.01%
3
– –
GTLS
361
DELISTED
Chart Industries
GTLS
– –
-14
Closed -$2K
GWRE icon
362
Guidewire Software
GWRE
$13.3B
– –
-16
Closed -$2K
GXC icon
363
State Street SPDR S&P China ETF
GXC
$478M
– –
-410
Closed -$36K
HALO icon
364
Halozyme
HALO
$9.88B
– –
-41
Closed -$2K
HLNE icon
365
Hamilton Lane
HLNE
$5.61B
– –
-22
Closed -$2K
HQY icon
366
HealthEquity
HQY
$8.78B
– –
-31
Closed -$2K
HUBS icon
367
HubSpot
HUBS
$12.7B
– –
-3
Closed -$1K
HURN icon
368
Huron Consulting
HURN
$2.43B
– –
-19
Closed -$1K
HXL icon
369
Hexcel
HXL
$7.87B
– –
-25
Closed -$1K
ICLR icon
370
Icon
ICLR
$12.1B
– –
-12
Closed -$3K
INCY icon
371
Incyte
INCY
$24.4B
– –
-19
Closed -$2K
INDS icon
372
Pacer Industrial Real Estate ETF
INDS
$117M
$0 οΉ€0.01%
10
– –
IOVA icon
373
Iovance Biotherapeutics
IOVA
$1.94B
– –
-57
Closed -$1K
IQLT icon
374
iShares MSCI Intl Quality Factor ETF
IQLT
$14B
– –
-30
Closed -$1.11M
ISTB icon
375
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
– –
-75
Closed -$3.63M
13 14
15
16 17

Similar funds

PSP
Principal Street Partners Memphis, Tennessee $613M AUM 26.72% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CT
Clearstead Trust Portland, Maine $613M AUM 25.73% 1-Year Est. Return
1SAMC
12th Street Asset Management Company Nashville, Tennessee $611M AUM 27.12% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $611M AUM
DTL
Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $611M AUM 25.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Providence Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Providence Capital Advisors held 482 positions worth $344M, down 16% from $408M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Providence Capital Advisors's Q2 2022 filing shows 11 new, 70 increased, 80 reduced and 174 closed positions. Its largest new stake was Aptiv: 45,637 shares worth $4.07M. The largest sale was Merck, an estimated $4.62M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Providence Capital Advisors's largest Q2 2022 buy was Aptiv: 45,637 shares worth $4.07M.
  • Providence Capital Advisors added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $5.42M increase.
  • Providence Capital Advisors's biggest Q2 2022 reduction was Merck, cutting an estimated $4.62M.
  • Providence Capital Advisors fully exited Innovator US Equity Power Buffer ETF January in Q2 2022, selling an estimated $3.75M.
  • Providence Capital Advisors's ten largest holdings make up 23% of its $344M portfolio in Q2 2022.
  • Providence Capital Advisors opened 11 new positions and closed 174 in Q2 2022.
  • Providence Capital Advisors's portfolio value fell 16% quarter-over-quarter to $344M.

Based on Providence Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.